
Homology Medicines Inc
NASDAQ:QTTB

Homology Medicines Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.36
50.59
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Homology Medicines Inc hold over its rivals?
What risks and challenges
does Homology Medicines Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Homology Medicines Inc.
Provide an overview of the primary business activities
of Homology Medicines Inc.
What unique competitive advantages
does Homology Medicines Inc hold over its rivals?
What risks and challenges
does Homology Medicines Inc face in the near future?
Has there been any significant insider trading activity
in Homology Medicines Inc recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Homology Medicines Inc.
Provide P/S
for Homology Medicines Inc.
Provide P/E
for Homology Medicines Inc.
Provide P/OCF
for Homology Medicines Inc.
Provide P/FCFE
for Homology Medicines Inc.
Provide P/B
for Homology Medicines Inc.
Provide EV/S
for Homology Medicines Inc.
Provide EV/GP
for Homology Medicines Inc.
Provide EV/EBITDA
for Homology Medicines Inc.
Provide EV/EBIT
for Homology Medicines Inc.
Provide EV/OCF
for Homology Medicines Inc.
Provide EV/FCFF
for Homology Medicines Inc.
Provide EV/IC
for Homology Medicines Inc.
Show me price targets
for Homology Medicines Inc made by professional analysts.
What are the Revenue projections
for Homology Medicines Inc?
How accurate were the past Revenue estimates
for Homology Medicines Inc?
What are the Net Income projections
for Homology Medicines Inc?
How accurate were the past Net Income estimates
for Homology Medicines Inc?
What are the EPS projections
for Homology Medicines Inc?
How accurate were the past EPS estimates
for Homology Medicines Inc?
What are the EBIT projections
for Homology Medicines Inc?
How accurate were the past EBIT estimates
for Homology Medicines Inc?
Compare the revenue forecasts
for Homology Medicines Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Homology Medicines Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Homology Medicines Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Homology Medicines Inc compared to its peers.
Compare the P/E ratios
of Homology Medicines Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Homology Medicines Inc with its peers.
Analyze the financial leverage
of Homology Medicines Inc compared to its main competitors.
Show all profitability ratios
for Homology Medicines Inc.
Provide ROE
for Homology Medicines Inc.
Provide ROA
for Homology Medicines Inc.
Provide ROIC
for Homology Medicines Inc.
Provide ROCE
for Homology Medicines Inc.
Provide Gross Margin
for Homology Medicines Inc.
Provide Operating Margin
for Homology Medicines Inc.
Provide Net Margin
for Homology Medicines Inc.
Provide FCF Margin
for Homology Medicines Inc.
Show all solvency ratios
for Homology Medicines Inc.
Provide D/E Ratio
for Homology Medicines Inc.
Provide D/A Ratio
for Homology Medicines Inc.
Provide Interest Coverage Ratio
for Homology Medicines Inc.
Provide Altman Z-Score Ratio
for Homology Medicines Inc.
Provide Quick Ratio
for Homology Medicines Inc.
Provide Current Ratio
for Homology Medicines Inc.
Provide Cash Ratio
for Homology Medicines Inc.
What is the historical Revenue growth
over the last 5 years for Homology Medicines Inc?
What is the historical Net Income growth
over the last 5 years for Homology Medicines Inc?
What is the current Free Cash Flow
of Homology Medicines Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Homology Medicines Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Homology Medicines Inc
NASDAQ:QTTB
|
21.4m USD | 0.6 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -196 782 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
369.6B USD | 16.3 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
159.5B USD | 18.8 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
147.4B USD | 10.9 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -574.1 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
101.2B USD | 20.6 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
106.9B AUD | 15.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
62.8B USD | 12.8 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
60.9B USD | -476.7 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -65.8 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Homology Medicines Inc
NASDAQ:QTTB
|
Average EV/EBITDA:
13.7
0.6
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -196 782 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
16.3
|
14%
|
1.2 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
18.8
|
10%
|
1.9 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
10.9
|
6%
|
1.8 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -574.1 | N/A | N/A |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
20.6
|
17%
|
1.2 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
15.7
|
11%
|
1.4 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
12.8
|
9%
|
1.4 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Negative Multiple: -476.7 | N/A | N/A |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -65.8 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.